Albemarle Corporation (NYSE:ALB) issued an update on its FY17 earnings guidance on Monday morning. The company provided EPS guidance of $4.20-4.40 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.36. The company issued revenue guidance of $2.90-3.05 billion, compared to the consensus revenue estimate of $2.95 billion.

Albemarle Corporation (NYSE ALB) traded up 2.91% on Monday, hitting $123.08. 3,815,419 shares of the company’s stock were exchanged. The stock has a market cap of $13.63 billion, a P/E ratio of 29.91 and a beta of 1.59. The firm has a 50 day moving average price of $111.82 and a 200-day moving average price of $105.71. Albemarle Corporation has a 52-week low of $75.11 and a 52-week high of $123.48.

Albemarle Corporation (NYSE:ALB) last announced its quarterly earnings results on Monday, August 7th. The specialty chemicals company reported $1.13 EPS for the quarter, beating the consensus estimate of $1.10 by $0.03. Albemarle Corporation had a return on equity of 11.97% and a net margin of 17.02%. The firm had revenue of $737.25 million for the quarter, compared to analyst estimates of $735.50 million. During the same quarter last year, the firm posted $0.93 earnings per share. The business’s revenue for the quarter was up 10.1% on a year-over-year basis. Analysts predict that Albemarle Corporation will post $4.37 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, October 2nd. Shareholders of record on Friday, September 15th will be paid a $0.32 dividend. The ex-dividend date is Thursday, September 14th. This represents a $1.28 annualized dividend and a yield of 1.04%. Albemarle Corporation’s dividend payout ratio (DPR) is presently 31.22%.

ALB has been the topic of several analyst reports. Jefferies Group LLC reiterated a buy rating and issued a $120.00 target price on shares of Albemarle Corporation in a research note on Friday, June 16th. Needham & Company LLC reiterated a buy rating and issued a $36.00 target price on shares of Albemarle Corporation in a research note on Thursday, June 29th. Royal Bank Of Canada reiterated a buy rating and issued a $132.00 target price on shares of Albemarle Corporation in a research note on Tuesday, April 18th. Nomura reiterated a buy rating and issued a $124.00 target price on shares of Albemarle Corporation in a research note on Friday, May 5th. Finally, Zacks Investment Research upgraded Albemarle Corporation from a hold rating to a buy rating and set a $121.00 target price on the stock in a research note on Friday, July 7th. Five investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has an average rating of Buy and a consensus price target of $105.50.

In other Albemarle Corporation news, Director Douglas L. Maine sold 10,000 shares of the firm’s stock in a transaction dated Monday, June 19th. The stock was sold at an average price of $107.94, for a total value of $1,079,400.00. Following the completion of the sale, the director now owns 24,150 shares of the company’s stock, valued at $2,606,751. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Scott Tozier sold 25,000 shares of the firm’s stock in a transaction dated Friday, July 7th. The stock was sold at an average price of $110.13, for a total value of $2,753,250.00. Following the completion of the sale, the chief financial officer now directly owns 57,506 shares of the company’s stock, valued at approximately $6,333,135.78. The disclosure for this sale can be found here. In the last three months, insiders sold 105,000 shares of company stock valued at $11,499,850. Corporate insiders own 0.74% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Albemarle Corporation (ALB) Issues FY17 Earnings Guidance” was reported by American Banking News and is owned by of American Banking News. If you are accessing this report on another publication, it was copied illegally and republished in violation of U.S. & international copyright and trademark law. The original version of this report can be read at https://www.americanbankingnews.com/2017/08/07/albemarle-corporation-alb-issues-fy17-earnings-guidance.html.

About Albemarle Corporation

Albemarle Corporation is a global developer, manufacturer and marketer of highly-engineered specialty chemicals. The Company operates through three segments: Lithium and Advanced Materials, Bromine Specialties and Refining Solutions. Lithium and Advanced Materials segment consist of two product categories: Lithium and Performance Catalyst Solutions.

Earnings History and Estimates for Albemarle Corporation (NYSE:ALB)

Receive News & Ratings for Albemarle Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle Corporation and related companies with MarketBeat.com's FREE daily email newsletter.